Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Erythroid precursor cell hemoglobin synthesis refers to the tightly regulated process by which developing red blood cell precursors (erythroblasts) synthesize hemoglobin, the oxygen-carrying protein essential for red blood cell function. This process involves coordinated production of heme and globin chains within erythroid cells in the bone marrow. It involves multiple enzymes like ALAS2 and ferrochelatase, and is regulated by factors such as heme, BACH1, HRI, and KLF1/EKLF. Defects can result in anemia or other hematologic disorders.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Erythroid Precursor Cell Hemoglobin Synthesis (N/A).